Published in

Impact Journals, Oncotarget, 48(7), p. 80046-80058, 2016

DOI: 10.18632/oncotarget.11098

Links

Tools

Export citation

Search in Google Scholar

First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors

Journal article published in 2015 by C. Willemien Menke-Van der Houven van Oordt, C. Willemien Menke-Van der Houven van Oordt, C. Willemien Menke-Van der Houven van Oordt, Carlos Gomez-Roca, Carla van Herpen, Andrew L. Coveler, Devalingam Mahalingam, Henk M. W. Verheul ORCID, Winette T. A. van der Graaf, Randolph Christen, Dominik Rüttinger, Stefan Weigand, Michael A. Cannarile, Florian Heil, Michael Brewster and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO